INTERREG 2 Seas – 3DMED – Development and integration of 3D printing for better patient care
Goal : Develop and improve 3D printing technologies to ease and raise its use in medical field for the benefit of patients
Actions carried out by Eurasanté :
- Help to set European users standards to foster adoption of 3D printing techniques by clinicians, hospitals, laboratories and patients
- Participation to communication and dissemination of project’s results
- Organisation of a French workshop to disseminate results towards actors from French value chain actors
- Manage market studies and prospective visits towards companies, industrials, clinicians, hospitals in order to evaluate and validate business models
- Help in valorisation of project’s results by protecting IP assets, creation of spin-outs and startups and setting-up of sustainable partnerships
Duration: 36 months
Planning: from 01/10/2018 to 31/03/2022
Budget: €6,843,950
Head of project: Technische Universiteit Delft (TUD) (NL)
- Stichting Materials innovation institute (NL)
- EXO-L BV (NL)
- Dutch Ophthalmic Research Center (International) B.V. (NL)
- Amber Implants B.V. (NL)
- Oceanz BV (NL)
- University of Ghent (BE)
- Strategisch Initiatief Materialen (BE)
- Avroxa bvba (BE)
- Association pour la Recherche et le Développement des Méthodes et Processus Industriels (FR)
- Eurasanté (FR)
- University of Lille – INSERM U1008 (FR)
- Régnier Orthopédie (FR)
- Meridian Technique Limited (UK)
- Oxford University (UK)
- Oxford MESTAR Limited (UK)
- 3D LifePrints (UK)
- Reinier de Graaf Groep (NL)
- University Medical Center Utrecht (NL)
- DEAM BV (NL)
- Dassault Systèmes (NL)
- Blue Sparrows MedTech Finance B.V. (NL)
- AZZENO/Cosmipolis Clinic (BE)
- CADskills BVBA (BE)
- Nelson Labs Europe NV (BE)
- In4care vzw (BE)
- Medtronic (FR)
- LATTICE MEDICAL (FR)
- Cousin Biotech (FR)
- Department of Plastic Surgery, Oxford University Hospitals NHS Foundation Trust (UK)
- Leiden University Medical Center (UK)
With the support of the European Regional Development Fund